FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is the indazole analogue of XLR-11.
![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H27FN2O |
Molar mass | 330.447 g·mol−1 |
3D model (JSmol) | |
| |
|
Legal status
editSweden's public health agency suggested classifying FAB-144 as a hazardous substance on November 10, 2014.[2]
See also
editReferences
edit- ^ "FAB-144". Cayman Chemical. Retrieved 23 July 2015.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.